Document type
ArticleVersion
Accepted versionPublication date
All rights reserved
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/108267
Tryptophanol-derived oxazolopiperidone lactams: identification of a hit compound as NMDA receptor antagonist
Journal Title
Director/Tutor
Additional contribution
Journal ISSN
Volume Title
Abstract
N-Methyl-D-Aspartate (NMDA) receptors are neuronal ionotropic channels that play an important role in memory and learning processes. Their exacerbated activation leads to neuron death by necrosis or apoptosis in a phenomenon called excitotoxicity. Compounds like memantine or amantadine act as antagonists of these receptors and are currently used for the treatment of Alzheimer's or Parkinson's diseases. We herein present the development of a series of new NMDA receptor antagonists using enantiopure tryptophanol and racemic δ-oxo-esters as synthetic precursors in only one synthetic step and good yields. The most active hit exhibited an IC50 of 63.4 µM in cultured rat cerebellar granule neurons thus being 1.5 fold more active than the positive control used, amantadine (IC50 = 92 µM). The versatility of our synthetic approach together with the well-defined absolute stereoutcome of the tryptophanol-derived oxazolopiperidones is currently being explored to produce valuable structure activity relationships for the development of new potent NMDAR antagonists.
Related resource
Subject (English)
Citation
Citation
PEREIRA, Nuno A. L., et al. Tryptophanol-derived oxazolopiperidone lactams: identification of a hit compound as NMDA receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 2014. Vol. 24, num. 15, pags. 3333 -3336. ISSN 0960-894X. [consulted: 17 of October of 2026]. Available at: https://hdl.handle.net/2445/108267